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Sulfur mustard or mustard gas (HD) and its monofunctional analog, 2-chloroethyl ethyl sulfide (CEES), or “half-mustard gas”,
are alkylating agents that induce DNA damage, oxidative stress, and inflammation. HD/CEES are rapidly absorbed in the skin
causing extensive injury. We hypothesize that antioxidant liposomes that deliver both water-soluble and lipid-soluble antioxidants
protect skin cells from immediate CEES-induced damage via attenuating oxidative stress. Liposomes containing water-soluble
antioxidants and/or lipid-soluble antioxidants were evaluated using in vitro model systems. Initially, we found that liposomes
containing encapsulated glutathione (GSH-liposomes) increased cell viability and attenuated production of reactive oxygen species
(ROS) in HaCaT cells exposed to CEES. Next, GSH-liposomes were tested in a human epidermal model, EpiDerm. In the EpiDerm,
GSH-liposomes administered simultaneously or 1 hour after CEES exposure (2.5 mM) increased cell viability, inhibited CEESinduced loss of ATP and attenuated changes in cellular morphology, but did not reduce caspase-3 activity. These findings paralleled
the previously described in vivo protective eﬀect of antioxidant liposomes in the rat lung and established the eﬀectiveness of GSHliposomes in a human epidermal model. This study provides a rationale for use of antioxidant liposomes against HD toxicity in
the skin considering further verification in animal models exposed to HD.

1. Introduction
Sulfur mustard (military code HD) is a weapon of massdestruction that is relatively simple to synthesize; it is lethal
in high doses and causes severe damage to skin, lungs,
respiratory tract, and eyes [1]. The most prominent toxic
eﬀects of HD are to dermal tissues where it produces severe
damage including extremely slow healing lesions and blisters,
which can ulcerate and promote secondary infections [2,
3]. Despite the long military history of HD, the molecular
mechanisms for its toxicity are not fully elucidated and an
eﬀective countermeasure has remained elusive. Both HD
and CEES (a monofunctional analog of sulfur mustard) are
alkylating agents that covalently react with nucleic acids,
proteins, and intracellular glutathione (GSH). GSH is a key
intracellular antioxidant that is depleted by exposure to HD

or CEES [4, 5]. A considerable body of evidence supports
the notion that oxidative stress is an important factor in
promoting HD/CEES toxicity and that antioxidants such as
GSH or NAC could be important countermeasures [5–13].
Recent studies have shown that GSH and NAC, especially
if used as a pretreatment, not only increase viability of CEEStreated keratinocytes, but also attenuate CEES toxicity in
SKH-1 hairless mouse skin [14, 15]. The eﬀectiveness of these
antioxidants in cultured cells and animal models suggests
that an oral application of GSH and/or NAC should be
considered as a potential countermeasure to the HD/CEES
toxicity in humans. However, certain diﬃculties of such
approach should be taken to account. First, the antioxidants
are eﬀective only during a short period after the exposure (≤1
hour). Second, the eﬀective dose of GSH in the animal experiments was 300 mg/kg [15], which suggests that the eﬀective
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GSH dose in human should be in the range of few tens of
grams. Therefore, a systemic application in humans would
be diﬃcult due to the requirement of large amounts of
solid or liquid antioxidants for a single treatment. A topical
application seems to be more appropriate; however, the
absorption of water-soluble antioxidants is minimal after
the topical application (less than 1% of the applied dose
penetrates the stratum corneum). Thus, we suggest that the
treatment design should be based on the combination of
the antioxidants with an eﬀective delivery system for topical
application.
Antioxidant liposomes, spherical nanoparticles consisting of phospholipid bilayer(s) with an aqueous compartment, possess the unique ability to eﬀectively deliver both
lipid soluble chemical antioxidants (in the lipid bilayer) and
water-soluble chemical antioxidants (in the aqueous phase)
[16, 17]. Moreover, liposomes rapidly penetrate the dermal
barrier making the delivery of water-soluble compounds as
eﬀective as lipid-soluble drugs [18]. In contrast with other
drug carriers such as DMSO [19], liposomes are absolutely
harmless to human skin since they are composed of naturally
occurring biodegradable phospholipids. In previous studies,
it has been demonstrated that antioxidant liposomes with
encapsulated NAC and antioxidant enzymes protect lung
epithelial cells and reduce lymphocyte infiltration in rats
intratracheally exposed to CEES [20–22]. We suggest that
antioxidant liposomes could be useful as a multifunctional
therapy since liposomal formulations similar to those used
in the rat lung studies could also be protective in skin. In
the present study, we tested the ability of several liposomal
formulations containing water-soluble antioxidants (NAC
or GSH) and/or lipid-soluble antioxidants (tocopherols or
alpha-lipoic acid) to attenuate CEES toxicity after the dermal
exposure. The protective eﬀects of liposomes were initially
studied in HaCaT human keratinocytes exposed to sulfur
mustard analog, CEES. The most protective GSH-containing
liposomes were then tested in a human epidermal model,
EpiDerm.

2. Materials and Methods
2.1. Materials and Reagents. Stemline Keratinocyte Medium
II (without L-glutamine, calcium-free), fluorimetric Caspase3 Assay Kit, Sigma Luciferase ATP Determination kit,
CEES, NAC, GSH, cholesterol, RRR-alpha-tocopherol, RRRgamma-tocopherol, R-alpha-lipoic acid, DMSO, EDTA, and
all organic solvents were obtained from Sigma Chemical
Company (Sigma-Aldrich Inc., St. Louis, Mo). CellTiter 96
Aqueous One Solution Cell Proliferation Assay kit based on
MTS (3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium, inner salt) was purchased
from Promega Corporation (Madison, Wis). Soybean phospholipid mixture phospholipon 90G was obtained from
American Lecithin Company (Oxford, Conn).
2.2. Cell Culture and Treatments. Spontaneously immortalized human keratinocytes HaCaT were purchased from
Cell Lines Service (Eppelheim, Germany). HaCaT cells were
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cultured at 37◦ C in a humidified incubator with 5% CO2
in Stemline Keratinocyte Medium II (without L-glutamine,
calcium-free) supplied with 10% fetal bovine serum Sigma
Chemical Company (St. Louis, Mo). Adherent cells were
subcultured over night in 96 well Costar tissue culture plates
in the Keratinocyte Medium II and treated with CEES in
the presence or absence of various concentrations of antioxidants or antioxidant liposomes as indicated in the figures.
CEES was used only as fresh stock solutions in anhydrous
DMSO, which was quickly mixed with culture medium immediately prior to incubation (final concentration of DMSO
was 1% (vol./vol.)). CEES final concentration of 1 mM was
chosen as it stably reduced HaCaT viability to 20–30% in
our experimental settings (preliminary experiments). This
observation is in accordance with findings published by other
investigators [14, 15].
EpiDerm human skin model system EPI-200 and conditioning medium were purchased from MatTek Corporation
(Ashland, Mass). EpiDerm is an in vitro human skin equivalent that consists of normal, human-derived epidermal keratinocytes (NHEK), which have been cultured to form a multilayered, highly diﬀerentiated model of the human epidermis (http://www.mattek.com/pages/products/epiderm). The
EpiDerm tissues in a clear plastic 24-well plate were reconditioned overnight according to the manufacturer’s instructions. CEES-containing media (freshly mixed) were applied
topically (250 μL per tissue) into the plate insert. Treatments
(free antioxidant solutions or antioxidant liposomes) premixed in the culture media were applied by changing the
bottom media. NAC and GSH are capable of scavenging
mustard electrophiles in solution [23, 24]. In order to prevent
direct interaction of the antioxidant liposomes with CEES,
GSH- or NAC-containing liposomes were added into the
bottom media, whereas CEES containing media were applied
to EpiDerm tissues topically.
Water-soluble antioxidants (GSH or NAC) were prepared
as 0.5 M stock solutions in PBS (pH adjusted to 7.4), filtersterilized, and stored at 4◦ C for two weeks or less. Lipophilic antioxidants (alpha-tocopherol, gamma-tocopherol,
or alpha-lipoic acid) were prepared as 50 mM stock solutions
in anhydrous ethanol and stored at −20◦ C.
2.3. Antioxidant Liposome Preparation and Application.
Antioxidant liposomes were prepared by extrusion of the
phospholipid/cholesterol dry film emulsified in PBS [25].
Six types of antioxidant liposomes (see Table 1) were made
by the extrusion technique using a small extruder apparatus
purchased from Avanti Polar Lipids Inc. (Alabaster, Ala)
according to manufacturer’s instructions. Prior to extrusion,
a lipid film was prepared in a 2 mL glass vial by mixing the
lipid-soluble component stock solutions in chloromethane
(phospholipon 90G, cholesterol with or without tocopherols
or alpha-lipoic acid) with subsequent evaporation of the
solvent under a nitrogen stream. The thin lipid film was then
hydrated and detached by vigorous mixing in PBS (which did
or did not contain water-soluble antioxidants GSH or NAC)
at 30◦ C. Solubilized large multilamellar vesicles were then
extruded through a polycarbonate membrane with 100 nm
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Table 1: Liposome composition.

Blank
Lipid components
Phospholipon 90G
cholesterol
α-tocopherol
γ-tocopherol
α-lipoic acid
Aqueous∗ components
GSH
NAC

0.71
0.29
0
0
0
0
0

Type of liposomes
GSH
NAC
AT
Concentration (mole fractions)
0.71
0.71
0.70
0.29
0.29
0.28
0
0
0.02
0
0
0
0
0
0
Concentration (mM)
200
0
0
0
200
0

GT

ALA

0.70
0.28
0
0.02
0

0.70
0.28
0
0
0.02

0
0

0
0

∗ All aqueous components were used as solutions in sterile PBS; liposomes that do not contain aqueous components were prepared with sterile PBS also.
Blank: Blank liposomes (contain no antioxidant); GSH: reduced glutathione; NAC: N-acetyl-L-cysteine; AT: alpha-tocopherol; GT: gamma-tocopherol; ALA:
alpha-lipoic acid.

size pores (Avanti Polar Lipids Inc., Alabaster, Ala) at 50◦ C.
The resulting liposomes, large unilamellar vesicles with a
mean diameter 120 ± 30 nm, were used the next day or
stored at 4◦ C for one week or less. Liposomes of this size
provide relatively high antioxidants/phospholipids ratio and
are not large enough to stimulate macrophages. Liposomes
of this size have been successfully used to attenuate CEES
toxicity in various models [20–22, 26]. Size distribution of
the liposomes was monitored in PBS by using dynamic light
scattering with a Nicomp 380 Particle Sizing Systems (Port
Richey, Fla). If liposomes were stored for more than one
day their size distribution, the main parameter of liposome
stability, was monitored again prior to the treatment. All of
our liposome preparations appeared stable for at least one
week.
In the tissue culture experiments, antioxidant liposomes
(Table 1) or antioxidant solutions/suspensions in PBS (as
controls) were applied to HaCaT cells simultaneously with
CEES. In the EpiDerm experiments, antioxidant liposomes
(containing 200 mM NAC or GSH encapsulated) or antioxidant solutions in PBS (as controls) were applied to EpiDerm
tissues via the bottom membrane (diluted 1 : 20 (v/v) in the
bottom media, thus providing a “calculated” final concentration of 10 mM) and simultaneously with CEES, which was
applied topically. Such application excluded direct contact
between CEES and liposomes, therefore preventing possible
absorption of CEES by liposomal phospholipids and subsequent hydrolysis of CEES by the aqueous liposomal interior.
Thus, liposomes did not directly interfere with CEES toxicity.
Overall design of these experiments was developed in accordance with the studies of CEES toxicity in the EpiDerm models [27–29] as well as with the studies of the protective eﬀects
of antioxidant liposomes in various models [20–22, 26].
2.4. Cell Viability Assays. The PI assay in the HaCaT cells was
performed by a slight modification of the method described
earlier [30]. Briefly, at the end of each experiment, cultured
cells in 96 well dark plates with clear bottom (200 μL of
medium per well) were incubated with PI (final concen-

tration 2 μg/mL) at 37◦ C for 30 min. PI fluorescence in the
dead cells was measured using a Fluostar Galaxy microplate
reader (BMG, Germany) at an excitation wavelength of
485 nm and an emission wavelength of 650 nm. The results
were calculated using the formula: viability (%) = 100 ×
(1– [(Test Sample – Low Control)/(High Control – Low
Control)]), where Test Sample is fluorescence of the cells
exposed to CEES or vehicle, Low Control is fluorescence
of the cells in medium without CEES or vehicle (negative
control, minimal fluorescence), High Control is fluorescence
of the cells incubated in medium containing 1% Triton X-100
(positive control, maximal fluorescence).
The MTS assay in the HaCaT cells and in the EpiDerm
tissues was performed using CellTiter 96 Aqueous One
Solution (MTS solution) according to the manufacturer’s
instruction. Briefly, at the end of each experiment, cultured
cells in clear plastic multiwell plates were incubated with
CellTiter 96 Aqueous One Solution (diluted 1 : 20 (v/v) with
medium) at 37◦ C for 1.5 hours. For HaCaT keratinocytes, the
MTS solution was applied by complete change of the culture
medium. For EpiDerm tissues, CellTiter 96 Aqueous One
Solution was diluted into fresh bottom media and applied
simultaneously with CEES or vehicle (applied topically). The
formazan derived from MTS is water soluble (unlike MTT
formazan product that needs to be dissolved in DMSO) and
does not require additional washout or any separation of the
cells prior to the OD measurement. The formazan product
produced by viable cells was detected by a visual inspection,
and the OD was measured at 590 nm with a Spectra Max Plus
384 microplate reader (Molecular Devices, Sunnyvale, Calif).
In our preliminary experiments, blank liposomes containing phospholipids and cholesterol only (see Table 1) did
not show any eﬀect on cell growth inhibition after 24 or
48 hour incubation; also, they did not attenuate the eﬀect
of CEES significantly (data not shown). Therefore, we used
blank liposomes as a control.
2.5. Caspase-3 and ATP Assays. Caspase-3 assay (an apoptosis index) and intracellular ATP measurements (drastic ATP
loss reflects necrosis) were performed by assaying cell lysates
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using the Caspase-3 Assay Kit and the Sigma Luciferase
ATP Determination kit, respectively, (Sigma-Aldrich Inc.,
St. Louis, Mo) according to manufacturer’s instructions.
Caspase-3 and ATP were measured in the cell lysates in order
to estimate relative contribution of apoptosis and necrosis
in the cell death mechanism in the EpiDerm. Staurosporine
(5 μM) was used to induce apoptosis (positive control). To
prepare cell lysates, EpiDerm tissues were carefully removed
from insert membranes using a sterile forceps and placed in
1.5 mL microcentrifuge tubes. A volume of 100 μL of Somatic
cell ATP releasing reagent (Sigma-Aldrich Inc., St. Louis, Mo)
was added to each tube. Each tissue was crushed into pieces
using a small pestle. The homogenized mixture was vortexed
briefly, and then frozen at −80◦ C. The next day the samples
were allowed to thaw for 15 min at room temperature. Then
the tubes were centrifuged at 4◦ C for 30 min at 16,000 ×g.
The supernatant fluids, designated the tissue lysates, were
transferred to fresh plastic tubes and were placed on ice
until assayed. All assays were performed immediately upon
preparation of tissue lysates.
2.6. Microscopic Examinations. At the end of incubation
with CellTiter 96 Aqueous One Solution (containing MTS)
EpiDerm tissues were rinsed with cold sterile PBS, removed
from insert membranes using forceps, placed on aluminium
foil and frozen at −80◦ C. For sectioning, each tissue was
fixed between two thick layers of OCT (Optimal Cutting
Temperature) compound. The “sandwich” was cut in half
and fixated on a microtable with OCT compound in order
to make vertical cuts. Tissue slices (25 μm thickness) were
made on Leica Rapid Sectioning Cryostat CM 1900 (Meyer
Instruments Inc., Houston, Tex), put on glass slides and
fixed with formalin solution (Sigma-Aldrich Inc., St. Louis,
Mo) without additional staining. Slides were examined and
photographed using a BX51 Olympus Microscope equipped
with a CC12 digital camera (Olympus America Inc., Center
Valley, Pa).
2.7. Fluorescent Microscopic Examinations. HaCaT cell density was adjusted to 2 × 105 /mL, and a 100 μL aliquot of
the cell suspension in media was placed in each well of an
8-well Lab-Tek chamber glass slide (Nunc, Rochester, NY).
Vehicle (1% DMSO) or CEES (1 mM) in the presence or
absence of 10 mM GSH (either encapsulated in the liposomes
(GSH-liposomes) or nonencapsulated (free GSH)) were simultaneously added to chamber slides and incubated for 6
hour (to evaluate ROS generation due to CEES exposure)
or 18 hours (to evaluate total thiol depletion due to CEES
exposure) at 37◦ C in 5% CO2 . The time period for the
ROS monitoring experiment was relatively short in order to
account for relatively short lifespan of ROS particles. At the
end of the incubation (6 or 18 hours, resp.) 100x stock solution of 6-carboxy-2 ,7 -dichlorodihydrofluorescein diacetate
(carDCFH-DA; H2 O2 -sensitive probe for intracellular ROS
monitoring) or 5-chloromethylfluorescein diacetate (CMFDA; nonprotein thiol sensitive probe for intracellular thiols,
including GSH) in DMSO was added (final carDCFHDA or CMF-DA concentration was 10 μM) and the slides
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were further incubated for 20 min at 37◦ C in the dark.
100 μM tert-butyl hydroperoxide (TBHP) was used to induce
oxidative stress in the absence of CEES or antioxidants
(positive control). The cells were washed with cold PBS
twice, observed, and digitally photographed using a MOTIC
inverted phase contrast fluorescence microscope equipped
with a Nikon Coolpix E4300 4-megapixel camera (Martin
Microscope, Easley, SC). Vehicle-treated sample stained with
carDCFH-DA were photographed as merged images (green
fluorescence and phase contrast) in order to visualize live
cells in the absence of fluorescence. The number of living cells
(green fluorescence) was determined after counting ≥200
cells in the squares (4 squares per sample) of same size for
each condition tested. Data were expressed as mean ± SD
percent reduction from control.
2.8. Statistical Analyses. Data were analyzed by ANOVA
followed with the Scheﬀe test for significance with P <
.05 using SPSS 17.0 for Windows (Chicago, Ill). Results
were expressed as the mean ± SD. In all the figures, mean
values not sharing a common letter are significantly diﬀerent
(P < .05). Mean values sharing a common letter are
not significantly diﬀerent. The mean values and standard
deviations of at least three independent experiments are
provided in all the figures.

3. Results
3.1. The Protective Eﬀect of Various Antioxidant Liposomes
in HaCaT Cells. We first performed a series of preliminary
experiments testing the eﬀect of various antioxidant liposome formulations in HaCaT keratinocytes exposed to CEES.
Six types of liposomes containing various antioxidants:
Blank (no antioxidants), NAC, GSH, alpha-tocopherol (AT),
gamma-tocopherol (GT), or alpha-lipoic acid (ALA) were
used for the initial experiments in HaCaT cells. Figure 1
shows HaCaT cell viability (MTS assay) after the exposure
to 1 mM CEES and simultaneous treatment with “free” or
liposome-encapsulated water-soluble antioxidants (NAC
or GSH). The eﬀects of antioxidant liposomes on the cell
proliferation were measured by the MTS assay after 18 hour
incubation (see Section 2). These results were confirmed
with viability assays using the fluorescent probe propidium
iodine (PI) that stains dead cells (data not shown). Both
assays showed similar patterns for cell survival (PI) and for
cell growth inhibition (MTS). Only water-soluble antioxidants (NAC and GSH) were eﬀective in these experiments.
Both 5 mM and 10 mM GSH-liposomes prevented CEESinduced decrease of cell viability in HaCaT keratinocytes
(Figure 1(a)). In a similar experiment, NAC-liposomes also
showed a dose-dependent increase in cell viability with
the maximum at 10 mM, however, the eﬀect was slightly
lower compared to GSH-liposomes (Figure 1(b)). GSHliposomes were the most protective since they increased cell
viability from 28% (blank liposomes) to 67% (10 mM GSH,
liposome encapsulated). However, the eﬀects of liposomeencapsulated NAC and GSH were equal to the eﬀects of
nonencapsulated “free” NAC and GSH. The lipid-soluble
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Figure 1: Protective eﬀects of “free” and liposome-encapsulated antioxidants in HaCaT cells. GSH (a) or NAC (b), either “free” (as stock
solutions in PBS) or encapsulated in the phospholipid-based liposomes (calculated final concentration as indicated), were applied to HaCaT
cells simultaneously with 1 mM CEES or vehicle (1% DMSO); blank liposomes (no antioxidant encapsulated) or PBS were used as controls
for GSH- or NAC-liposomes and for “free” GSH or NAC, respectively. Cells were incubated at 37◦ C for 18 hours. Cell viability was measured
using the MTS assay (see Section 2). Mean values not sharing a common letter are significantly diﬀerent (P < .05).

antioxidants (alpha-tocopherol, gamma-tocopherol, or alpha-lipoic acid) were not protective when liposome-encapsulated or as suspensions in PBS (data not shown).
3.2. GSH Prevents ROS Generation and Thiol Depletion in
HaCaT Cells. In order to show that CEES induces oxidative
stress in the HaCaT cells we performed a series of fluorescent
microscopy experiments monitoring ROS and thiol status of
the CEES-treated cells in the presence and in the absence
of GSH-liposomes (Figure 2). As evidenced by carDCFHDA fluorescence, intracellular H2 O2 , a major marker of
ROS generation, was enhanced upon the CEES treatment
(6 hours); however, in the presence of GSH-liposomes or
“free” GSH, ROS production was almost fully abolished
(Figure 2(a)). CEES exposure (18 hours) also reduced average number of viable cells counted under microscope (14.7
± 8.2% of control) and promoted total thiol depletion
(Figure 2(b)); the eﬀect was attenuated in the presence of
GSH-liposomes (33.1 ± 9.5% of control), as well as in the
presence of “free” GSH (28.4 ± 11.5% of control). These
observations provide additional evidence that the GSHliposomes eﬀectively protect human keratinocytes exposed
to CEES and attenuate CEES-induced ROS production and
thiol depletion, although the eﬀect of liposome-encapsulated
GSH was similar to the eﬀect of “free” GSH. These data
also suggest that in HaCaT keratinocytes, GSH-liposomes
provide eﬀective intracellular GSH delivery.
3.3. The Eﬀects of Antioxidant Liposomes in the EpiDerm
Model. EpiDerm tissue consists of organized basal, spinous,
granular, and cornified layers of diﬀerentiating epidermal
human keratinocytes that closely mimic human epidermis.
At present, EpiDerm is one of the best available in vitro
models of human skin and has successfully been used to
study CEES toxicity in vitro [27, 28]. At first, we explored

cytotoxic eﬀect of CEES in EpiDerm tissues. A dosedependent decrease of cell viability due to CEES (0.5–
5.0 mM) exposure was observed (data not shown). CEES
concentration of 2.5 mM reduced cell viability within the
EpiDerm tissues to 48 ± 8.6%, and this concentration was
chosen for the following experiments to study the eﬀect of
antioxidants.
We tested the protective eﬀect of GSH- and NACcontaining liposomes in EpiDerm tissues exposed to CEES.
We found that only GSH-liposomes increased cell viability
(Figure 3(a)) and reduced ATP depletion (Figure 3(b)) in
the EpiDerm tissues topically exposed to 2.5 mM CEES.
GSH-liposomes added immediately after CEES provided an
extremely eﬀective countermeasure to CEES toxicity since
both cell viability (Figure 3(a)) and ATP level (Figure 3(b))
did not significantly decrease from their original levels as
observed in cells treated with vehicle alone. The attenuation
of ATP depletion in keratinocytes evidenced that GSHliposomes reduce necrosis induced by CEES.
3.4. The Eﬀect of Antioxidant Liposomes on Apoptosis in
the EpiDerm Model. We also evaluated the ability of GSHliposomes to influence apoptosis in CEES-treated EpiDerm
tissues using the caspase-3 assay (Figure 4). CEES and HD
induce both apoptosis and necrosis in human cell lines
including HaCaT keratinocytes. However, relatively low doses of HD induce mostly apoptosis, whereas higher doses promote necrosis [31, 32]. Thus, it is likely that CEES ≥2.5 mM
would promote mostly necrosis with only limited induction
of apoptosis. Indeed, at a level of 2.5 mM, CEES induced
a relatively low level of apoptosis in EpiDerm (Figure 4).
Considering the marked loss of ATP (Figure 3(b)), necrosis,
but not apoptosis is likely the major cause of cell death at
this level of CEES. Figure 4 also shows that GSH-liposomes
did not inhibit the apoptosis induced by 2.5 mM CEES.
These experiments suggest that GSH-liposomes are eﬀective
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TBHP (pos. cont.)

Vehicle + free GSH

Vehicle + GSH-liposomes

1.5 mM CEES

CEES + free GSH

CEES + GSH-liposomes

(a)

Vehicle

Vehicle + free GSH

Vehicle + GSH-liposomes

1.5 mM CEES

CEES + free GSH

CEES + GSH-liposomes

(b)

Figure 2: GSH prevents ROS generation and thiol depletion in HaCaT cells. HaCaT cells were treated with vehicle (1% DMSO) or 1.5 mM
CEES (as indicated) in the presence or absence of “free” GSH or GSH-liposomes (as indicated), simultaneously. Cells were incubated at
37◦ C for 6 hours and then stained with 10 μM carDCFH-DA to monitor ROS generation (a); alternatively, cells were incubated at 37◦ C for
18 hours and then stained with 10 μM CMF-DA to access intracellular nonprotein thiols (b). 100 μM TBHP (tert-butyl hydroperoxide) was
used as a positive control (to induce oxidative stress). Live cells were photographed under a fluorescent microscope (200x magnification)
equipped with a standard FITC filter. Vehicle-treated sample stained with carDCFH-DA (a) shows merged images (green fluorescence and
phase contrast) in order to visualize live cells in the absence of fluorescence.

in blocking CEES toxicity and necrosis, but do not prevent
apoptosis in the EpiDerm model.
3.5. The Protective Eﬀect of GSH-Liposomes in EpiDerm Model
(Posttreatment). In order to test the potential protective
eﬀect of GSH-liposomes under posttreatment conditions,
we performed an experiment, in which NAC- or GSH-

liposomes were applied to EpiDerm one or two hours after
the CEES (2.5 mM) exposure. Only GSH-liposomes and
“free” GSH showed significant protection in this experiment (Figure 5). In the EpiDerm tissues, CEES exposure
reduced cell viability to 24 ± 5%; GSH-liposomes applied
simultaneously with CEES altered cell viability to 87 ± 9%;
GSH-liposomes applied one hour after CEES altered cell
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liposomes (B-liposomes) or GSH-liposomes (as indicated) applied
simultaneously with CEES or vehicle, but into the bottom media;
the tissues were incubated at 37◦ C for 18 hours. Final “calculated”
concentration of GSH was 10 mM (see Section 2). Caspase-3
activity was assayed in the tissue homogenates by the caspase-3 assay
(see Section 2). Blank: blank buﬀer (negative control); Staur.: 5 μM
staurosporine (positive control). Means not sharing a common
letter are significantly diﬀerent (P < .05).

Figure 5: Protective eﬀects of GSH-liposomes or free GSH in EpiDerm
(posttreatment). EpiDerm tissues were exposed topically to 2.5 mM
CEES or vehicle (1% DMSO) in the absence or presence of Blank
liposomes (B-liposomes) or GSH-liposomes (as indicated) applied
simultaneously with CEES or vehicle, but into the bottom media
(sim: simultaneous application; post: 1 hour post-treatment). Final
“calculated” concentration of GSH was 10 mM (see Section 2).
Cell viability was monitored after 18 hours by the MTS assay (see
Section 2). Means not sharing a common letter are significantly
diﬀerent (P < .05).

viability to 52 ± 11%; GSH-liposomes applied two hours
after CEES altered cell viability to 32 ± 12%. Although the
latter (two hours) eﬀect was not significant, the eﬀect of onehour posttreatment with GSH-liposomes was statistically
significant, and the toxicity of CEES was attenuated substantially (two-fold diﬀerence). NAC-liposomes did not show any

statistically significant protective eﬀect in the posttreatment
experiments (data not shown).
3.6. The Influence of GSH-Liposomes on Cellular Morphology Changes in EpiDerm. It is known that HD and its
analogs induce morphological changes in keratinocytes, in
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Figure 6: Protective eﬀect of GSH-liposomes in the EpiDerm model. EpiDerm tissues were topically exposed to vehicle (1% DMSO) or 2.5 mM
CEES in the absence or presence of GSH-liposomes or Blank liposomes (B-liposomes). After the MTS assay EpiDerm tissues were frozen,
dissected, and photographed under a light microscope with 400x magnification (see Section 2). Violet color reflects the accumulation of the
MTS formazan product in the proliferating keratinocytes. Note the disruption of the keratin filament structure in the stratum corneum in
the presence of CEES, and the increase of proliferating (violet) basal keratinocytes in the presence of GSH-liposomes.

particular, HD aﬀects size and shape of the cells and induces
fragmentation of the extracellular matrix [3]. In order to
determine whether GSH-liposomes influence keratinocyte
morphology, we performed microscopic examinations of
EpiDerm tissues incubated with CEES in the presence or
absence of GSH-liposomes; tissues were stained with MTS
at the end of the incubation to visualize viable cells. After
CEES (2.5 mM) exposure the apical side of the keratinocyte
multilayer showed the matrix disassembly (the cells lost their
compact structure within the tissue and prominent gaps
appear in the matrix); the integrity of the cell multilayer
was markedly disturbed and the majority of proliferating
cells were detached and lost. The remaining cells formed
a dense structure with a very limited number of live cells.
The remaining live cells appeared violet in color due to the
reduction of MTS dye by functioning mitochondria; these
cells showed size reduction and round shape (Figure 6).
This observation is in agreement with recent study of
CEES toxicity in the EpiDerm full-thickness skin equivalents
[29]. Treatment with blank liposomes (composed with
phospholipids only) did not aﬀect the CEES-exposed cells,
however, marked changes were observed upon simultaneous
treatment with CEES and GSH liposomes (Figure 6). The
number of live keratinocytes increased as observed by
the MTS staining; some live cells retained normal shape;
however, the overall integrity of the tissue was somewhat

lower if compared to the control (tissues exposed to vehicle
only).

4. Discussion
Our studies with the human epidermal model, EpiDerm,
showed that GSH, both “free” and “liposome encapsulated,”
attenuated toxicity induced by CEES, a mustard gas analog.
In our experimental settings, antioxidant liposomes and
CEES were applied separately (topically and to the bottom
media, resp.) in order to prevent their direct interaction
and scavenging of CEES by the liposomes. Systemic application of free GSH would require consumption of large
amounts of solid or liquid antioxidants because hydrophilic
compounds poorly penetrate the stratum corneum; therefore, antioxidant liposomes would provide a reasonable
alternative, especially after the dermal exposure. Moreover,
the liposome design presents an additional advantage as it
allows encapsulating of multiple lipophilic and hydrophilic
components. For instance, antioxidants can be combined
with anti-inflammatory drugs as inflammation plays a role
in the development of skin lesions [33].
At a relatively high CEES dose (2.5 mM), the major cause
of cell death in our studies was necrosis with only a slight
additional eﬀect caused by apoptosis. Our results indicated
that the GSH liposomes not only enhanced cell viability in
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EpiDerm tissues exposed to CEES, but also reduced necrosis
as evidenced by inhibition of ATP depletion induced by CEES
exposure. On the other hand, as shown by the caspase-3
activity measurements, GSH liposomes had no significant
eﬀect on CEES-induced apoptosis (2.5 mM CEES). This is
in accord with numerous studies of CEES or HD toxicity
to various cell lines including human keratinocytes [3]. In
endothelial cells and lymphocytes [6, 34, 35] and also in
HaCaT keratinocytes [31, 32], relatively low doses of HD
induced mostly apoptosis, whereas higher doses promoted
necrosis. Chiarugi, [36] has shown that a potent alkylating
agent, if applied to the cells at a suﬃcient level, induces a
“programmable” form of necrosis due to a genotoxic stress.
Necrosis is a more inflammatory form of cell death. In epidermal keratinocytes, necrosis, but not apoptosis, promotes
inflammatory responses [37–40]. In various skin models, the
open wounds due to HD exposure were highly susceptible
to infections and showed many typical characteristics of
necrotic tissues [2, 31]. Thus, in the search for therapeutic
countermeasures to HD, it is important to show that the
prospective treatment not only increases cell viability but also
reduces necrosis. In our recent work, we have discussed an
“apoptosis-to-necrosis switch” in the HaCaT cells exposed to
CEES [41].
The molecular mechanisms of CEES/HD toxicity in
human skin have not been fully investigated. Recent findings
strongly suggest, however, that these mechanisms are complex; they involve DNA and other macromolecular damage,
oxidative stress and inflammation [3, 33]. It is widely
accepted that ROS generation and oxidative damage play a
critical role in these mechanisms. In the EpiDerm model,
GSH liposomes showed significant protective eﬀect even
when applied 1 hour after CEES exposure. This observation
further confirmed previous in vitro studies of CEES/HD
toxicity, which have demonstrated that the antioxidants
that reduce oxidative stress and prevent thiol depletion also
attenuate CEES toxicity, whereas oxidants (hydrogen peroxide) [4] and agents that deplete intracellular glutathione
(buthionine sulphoximine) [6, 42] sensitize human cell lines,
in particular HaCaT [42], to CEES/HD toxicity. Thus, our
study provides additional evidence of the critical role of
oxidative stress in the pathogenesis of CEES/HD-induced
injury in the skin. Although the protective eﬀects of various
antioxidants are well documented both in vitro and in vivo
[2, 3], it is possible that in the human skin, the antioxidants
are eﬀective only when applied prior to or short time after
(about 1 hour) CEES/HD exposure. For instance, in human
endothelial cells, NAC altered cell viability only when applied
simultaneously or prior to HD [6]. Similarly, in a guinea
pig model, superoxide dismutase, a powerful antioxidant
enzyme, reduced skin lesions only when applied prior to
HD exposure [43]. It should be taken into account that
the main direct chemical impact of the alkylating agents,
such as HD or CEES, within the cell is attributable to the
DNA damage derived from rapid alkylation of guanines
by mustard sulfonium ions [3, 24]; NAC and GSH (as
nucleophilic scavengers) are capable of scavenging mustard
electrophiles in the cytosol [23, 24]. However, this direct
detoxification is possible only during a short time after
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the exposure, and other nucleophilic scavengers, for example, thiopurines [23] or exogenous peroxidases [44], are
more eﬀective in degrading of HD or CEES. Nevertheless,
antioxidants and antioxidant liposomes have shown a great
potential in preventive treatment of CEES/HD toxicity [3–
5, 9, 10, 20, 21, 26, 34, 42, 45–48]. In addition, it is well
known that mammalian skin cells exposed to CEES/HD
release proinflammatory cytokines [27, 28, 37, 49] and other
immune stimulators [50]. These immune factors mediate
inflammatory responses that contribute to the development
of skin lesions [33]. Therefore, in a long run, it is critical not
only to protect keratinocytes from immediate cell injuries,
but also to reduce the inflammatory responses in the skin
[3, 33]. This approach will require deeper understanding of
the molecular mechanisms of CEES/HD toxicity in multicelltype and animal models.
In summary, we found that GSH liposomes have shown a
protective eﬀect (viability increase, ATP content protection,
oxidative stress reduction) in the EpiDerm model exposed to
CEES, a close analog of mustard gas. The molecular mechanisms of the protective eﬀect of GSH-liposomes involved
reduction of necrosis (but not apoptosis). In addition, GSH
liposomes attenuated ROS generation and intracellular thiol
depletion that were induced by CEES. We suggest that in
the EpiDerm model, GSH-liposomes protect the cells from
necrosis not only by scavenging of CEES electrophiles, but
also by reduction of oxidative stress and inflammation.
The hypothesis, however, needs more evidence, and that is
being addressed in a separate study. Although the protective
eﬀect of liposome-encapsulated GSH was limited in time
and not statistically diﬀerent to the eﬀect of “free” GSH,
we suggest that preventive or “quick-response” antioxidant
therapy may be a useful strategy against mustard toxicity
in human skin, especially considering the fact that watersoluble antioxidants cannot penetrate epidermis if applied
to the skin as a solution, whereas the liposomes possess
superior delivery abilities in dermal applications [18]. Taking
into account previously described antioxidant liposomederived protection in lung tissues [20–22, 26], we suggest
that a multifunctional liposomal formulation containing
encapsulated antioxidants will be eﬀective against sulfur
mustard toxicity both in the skin and in the lung.
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